カテゴリ： MarketLine, マレーシア, 企業調査

Fraser & Neave Holdings Bhd：戦略・SWOT・企業財務分析

◆英語タイトル：Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015277
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：32
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：マレーシア
◆産業分野：消費財
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Fraser & Neave Holdings Bhd – Strategy, SWOT and Corporate Finance Report
Summary

Fraser & Neave Holdings Bhd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Fraser & Neave Holdings Bhd (F&NHB) is a producer and marketer of soft drinks and dairy products. It is also involved in property development activities and the provision of management services. Its soft drinks division offers carbonated soft drinks, sports drinks, Asian drinks, iced/rtd tea drinks, juices and energy drinks through its four manufacturing plants. Its dairy products division offers F&N sweetened condensed milk, F&N evaporated milk, pasteurized milk, sterilized and ultra-heat treatment (UHT) milk, and pasteurized juices. The company is also involved in commercial development of properties through its business parks. The company has a presence in Thailand, Singapore, Indonesia, Brunei and Malaysia. F&NHB is headquartered in Kuala Lumpur, Malaysia.

Scope

- Detailed information on Fraser & Neave Holdings Bhd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Fraser & Neave Holdings Bhd in the form of a SWOT analysis
- An in-depth view of the business model of Fraser & Neave Holdings Bhd including a breakdown and examination of key business segments
- Intelligence on Fraser & Neave Holdings Bhd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Fraser & Neave Holdings Bhd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Fraser & Neave Holdings Bhd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Fraser & Neave Holdings Bhd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Fraser & Neave Holdings Bhd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Fraser & Neave Holdings Bhd: Company Overview
Fraser & Neave Holdings Bhd: Overview and Key Facts
Fraser & Neave Holdings Bhd: Overview
Fraser & Neave Holdings Bhd: Key Facts
Fraser & Neave Holdings Bhd: Key Employees
Fraser & Neave Holdings Bhd: Key Employee Biographies
Fraser & Neave Holdings Bhd: Major Products and Services
Fraser & Neave Holdings Bhd: Company History
Fraser & Neave Holdings Bhd: Management Statement
Fraser & Neave Holdings Bhd: Key Competitors
Fraser & Neave Holdings Bhd: Company Analysis
Fraser & Neave Holdings Bhd: Business Description
Fraser & Neave Holdings Bhd: SWOT Analysis
Fraser & Neave Holdings Bhd: SWOT Overview
Fraser & Neave Holdings Bhd: Strengths
Fraser & Neave Holdings Bhd: Weaknesses
Fraser & Neave Holdings Bhd: Opportunities
Fraser & Neave Holdings Bhd: Threats
Fraser & Neave Holdings Bhd: Corporate Financial Deals Activity
Fraser & Neave Holdings Bhd: Financial Deals Overview
Fraser & Neave Holdings Bhd: Top Deals 2013 – 2017YTD*
Fraser & Neave Holdings Bhd: Divestments
Fraser & Neave Holdings Bhd: Recent Developments
Fraser & Neave Holdings Bhd: News and Events Summary
Fraser & Neave Holdings Bhd: Corporate Governance
Fraser & Neave Holdings Bhd: Financial Deals
Fraser & Neave Holdings Bhd: Financial Performance
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Fraser & Neave Holdings Bhd: Key Facts
Table 2: Fraser & Neave Holdings Bhd: Key Employees
Table 3: Fraser & Neave Holdings Bhd: Key Competitors
Table 4: Fraser & Neave Holdings Bhd: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 5: Fraser & Neave Holdings Bhd: Top Deals 2013 - 2017YTD*
Table 6: Fraser & Neave Holdings Bhd: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 7: Fraser & Neave Holdings Bhd: Divestments by Geography (2013 - YTD*2017)
Table 8: Fraser & Neave Holdings Bhd: News and Events Summary
Table 9: Fraser & Neave Holdings Bhd: Corporate Governance
Table 10: Fraser & Neave Holdings Bhd: Financial Deals
Table 11: Fraser & Neave Holdings Bhd: Financial Performance

★海外企業調査レポート[Fraser & Neave Holdings Bhd：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Enzymatica AB (ENZY)：企業の財務・戦略的SWOT分析
    Summary Enzymatica AB (Enzymatica) is a life science company that develops and markets medical products for various virus and bacterial infections. The company offers mouth sprays and veterinary products. Its veterinary products comprise dental health and skin relief enzyme based gels, dental and de …
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development-製薬・医療分野：企業M&A・提携分析
    Summary Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the …
  • Electricity Supply Board：電力：M&Aディール及び事業提携情報
    Summary Electricity Supply Board (ESB) owned by Irish Government, is a diversified and vertically integrated utility that generates, transmits, and distributes and supplies electricity and gas. The company builds, owns and maintains transmission and distribution networks. It offers meter reading, an …
  • Actinium Pharmaceuticals Inc (ATNM)：企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (Actinium), formerly Cactus Ventures Inc, is a biopharmaceutical company. It develops antibody radiation conjugates (ARC), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company's pipeline products include Iomab- …
  • Insmed Inc (INSM)：製薬・医療：M&Aディール及び事業提携情報
    Summary Insmed Inc (Insmed) is a biopharmaceutical company that focuses on rare diseases. Its lead product candidate, Arikayce (liposomal amikacin for inhalation), is indicated for the treatment of nontuberculous mycobacteria (NTM) lung disease in adult patients. Its other clinical pipeline are bein …
  • N V Nederlandse Gasunie：企業の戦略・SWOT・財務分析
    N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report Summary N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Qatar Airways Group Q.C.S.C.：企業の戦略・SWOT・財務分析
    Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report Summary Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Galectin Therapeutics Inc (GALT)-医療機器分野：企業M&A・提携分析
    Summary Galectin Therapeutics Inc (Galectin Therapeutics), formerly Pro-Pharmaceuticals Inc is a biotechnology company that discovers, develops and commercializes therapies for fibrotic disease and cancer. The company's products comprise GR-MD-02 and GM-CT-01. Its GR-MD-02 is a drug candidate used f …
  • Servier Canada Inc-製薬・医療分野：企業M&A・提携分析
    Summary Servier Canada Inc (SCI), a subsidiary of Les Laboratoires Servier SAS is a manufacturer and distributor of generic and ethical products. The company’s products include perindopril erbumine tablets, perindopril erbumine indaparride tablets, glidazide modified release tablets, glidazide table …
  • Bangkok Chain Hospital Public Co Ltd (BCH)：企業の財務・戦略的SWOT分析
    Bangkok Chain Hospital Public Co Ltd (BCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Calamos Asset Management, Inc.
    Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Oxford Nanopore Technologies Ltd：企業の戦略的SWOT分析
    Oxford Nanopore Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Star Gas Partners L.P.：企業の戦略・SWOT・財務分析
    Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Korea Gas Corp (036460)-石油・ガス分野：企業M&A・提携分析
    Summary Korea Gas Corp (KOGAS) is a vertically integrated natural gas company active in upstream midstream and downstream segments of natural gas industry. It explores, produces and distributes natural gas. The company also purifies and sells by-products; imports and exports natural gas and liquefie …
  • Biomay AG-製薬・医療分野：企業M&A・提携分析
    Summary Biomay AG (Biomay) discovers and develops disease modifying allergy therapeutics. The company develops peptide carrier fusion vaccines for allergy immunotherapy. Its pipeline product portfolio comprises investigation candidates targeted against IgE mediated diseases, grass pollen allergy, ho …
  • Cosmo Pharmaceuticals NV (COPN)：企業の財務・戦略的SWOT分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Landesbank Berlin Holding AG：企業の戦略・SWOT・財務情報
    Landesbank Berlin Holding AG - Strategy, SWOT and Corporate Finance Report Summary Landesbank Berlin Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Oxford Immunotec Ltd：企業の製品パイプライン分析2018
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …
  • Kamada Ltd (KMDA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Kamada Ltd (Kamada) is a biopharmaceutical company that develops, manufactures and markets specialty proteins, specific immunoglobulins and other prescription medicines. Its major products include pulmonary related medicines, immunoglobins, vaccines and critical care medicines. It also offer …
  • Aeglea BioTherapeutics Inc (AGLE)-製薬・医療分野：企業M&A・提携分析
    Summary Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company’s product pipeline comprises AEB1102, AEB …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆